Nanogroup SA Cash Flow Conversion Efficiency
Nanogroup SA cash flow conversion efficiency. Based on the latest financial reports, Nanogroup SA (NNG) has a cash flow conversion efficiency ratio of -0.141x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (zł-1.60 Million ≈ $-440.62K USD) by net assets (zł11.37 Million ≈ $3.13 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Nanogroup SA (2015–2024)
Cash flow conversion efficiency of Nanogroup SA from 2015 to 2024. This chart illustrates how Nanogroup SA's cash flow conversion efficiency has evolved over time, based on yearly financial data. View NNG stock price for real-time trading data and today's change.
Nanogroup SA Cash Flow Conversion Ratio Explained
Nanogroup SA cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Nanogroup SA Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Nanogroup SA ranked by their cash flow conversion efficiency. Also see how much is Nanogroup SA worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Aseana Properties Limited
LSE:ASPL
|
0.070x |
|
Selva Gida Sanayi AS
IS:SELVA
|
-0.049x |
|
IVP Limited
NSE:IVP
|
0.067x |
|
Sidma S.A. Steel Products
AT:SIDMA
|
0.036x |
|
FAR Ltd
AU:FAR
|
-0.008x |
|
Cannindah Resources Ltd
AU:CAE
|
-0.041x |
|
Union Plastic Public Company Limited
BK:UP
|
-0.006x |
|
Pelat Timah Nusantara Tbk
JK:NIKL
|
0.015x |
Annual Cash Flow Conversion Efficiency for Nanogroup SA (2015–2024)
The table below shows the annual cash flow conversion efficiency of Nanogroup SA from 2015 to 2024. Review Nanogroup SA (NNG) FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | zł15.93 Million ≈ $4.38 Million |
zł-5.72 Million ≈ $-1.57 Million |
-0.359x | +61.11% |
| 2023-12-31 | zł5.16 Million ≈ $1.42 Million |
zł-4.76 Million ≈ $-1.31 Million |
-0.923x | -94.91% |
| 2022-12-31 | zł7.78 Million ≈ $2.14 Million |
zł-3.68 Million ≈ $-1.01 Million |
-0.473x | -23.81% |
| 2021-12-31 | zł8.37 Million ≈ $2.30 Million |
zł-3.20 Million ≈ $-880.44K |
-0.382x | -432.65% |
| 2020-12-31 | zł18.77 Million ≈ $5.16 Million |
zł-1.35 Million ≈ $-370.81K |
-0.072x | +39.41% |
| 2019-12-31 | zł13.31 Million ≈ $3.66 Million |
zł-1.58 Million ≈ $-434.00K |
-0.118x | +47.04% |
| 2018-12-31 | zł15.52 Million ≈ $4.27 Million |
zł-3.47 Million ≈ $-955.84K |
-0.224x | -22.01% |
| 2017-12-31 | zł14.17 Million ≈ $3.90 Million |
zł-2.60 Million ≈ $-714.92K |
-0.183x | -202.75% |
| 2016-12-31 | zł12.75 Million ≈ $3.51 Million |
zł-772.07K ≈ $-212.49K |
-0.061x | -153.46% |
| 2015-12-31 | zł5.28 Million ≈ $1.45 Million |
zł-126.11K ≈ $-34.71K |
-0.024x | -- |
About Nanogroup SA
NanoGroup S.A. operates as a biotechnology company in Poland. The company develops and licenses early-stage pre-clinical and IND solutions to international biotech and pharma companies. It also manages a portfolio of companies that manages projects for the need of modern medicine in the field of oncology and transplantology. The company was incorporated in 2016 and is based in Warsaw, Poland.